Imiquimod-induced localized vitiligo-like hypopigmentation

摘要：

Introduction Imiquimod is an immune response modifier,currently the 5％ imiquimod cream is approved for treatment of extemal genital,perianal warts,superficial basal cell carcinoma,and actinic keratoses.Its anti-viral activity and anti-tumoral activity seem to be dependent on focal activation of the immune system with induction,synthesis,and release of cytokines,such as interferonalpha,interleukin-12 and tumor necrosis factor alpha”1-2”.

所属期刊栏目：1

在线出版日期：2018-10-29（万方平台首次上网日期，不代表论文的发表时间）

页数：共4页

页码：189-192